Akoya Biosciences, Inc. (AKYA)
NASDAQ: AKYA · Real-Time Price · USD
1.430
-0.060 (-4.03%)
At close: Mar 28, 2025, 4:00 PM
1.427
-0.003 (-0.21%)
After-hours: Mar 28, 2025, 7:15 PM EDT
Akoya Biosciences Employees
Akoya Biosciences had 205 employees as of December 31, 2024. The number of employees decreased by 125 or -37.88% compared to the previous year.
Employees
205
Change (1Y)
-125
Growth (1Y)
-37.88%
Revenue / Employee
$398,400
Profits / Employee
-$270,073
Market Cap
71.24M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 205 | -125 | -37.88% |
| Dec 31, 2023 | 330 | -39 | -10.57% |
| Dec 31, 2022 | 369 | 50 | 15.67% |
| Dec 31, 2021 | 319 | 150 | 88.76% |
| Dec 31, 2020 | 169 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AKYA News
- 6 days ago - Tikvah Management Announces Intention to Vote AGAINST Quanterix's Proposed Merger with Akoya Biosciences - Business Wire
- 13 days ago - Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today's Earnings Call - Business Wire
- 13 days ago - Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results - GlobeNewsWire
- 19 days ago - Kent Lake Issues Investor Presentation Detailing Opposition to Quanterix's Proposed Merger with Akoya Biosciences - Business Wire
- 5 weeks ago - Kent Lake Issues Letter to Quanterix Shareholders Regarding Opposition to the Company's Proposed Merger with Akoya Biosciences - Business Wire
- 7 weeks ago - Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels - GlobeNewsWire
- 2 months ago - Akoya Biosciences Selects Argonaut Manufacturing Services as IVD Manufacturing Partner - Business Wire
- 2 months ago - AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA - Business Wire